Sinemet and Erythrocyte sedimentation rate increased - a phase IV clinical study of FDA data
We study 27,342 people who have side effects when taking Sinemet. Erythrocyte sedimentation rate increased is found, especially among people who are male, 60+ old, also take Requip.
The phase IV clinical study analyzes which people take Sinemet and have Erythrocyte sedimentation rate increased. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
27,342 people reported to have side effects when taking Sinemet.
Among them, 19 people (0.07%) have Erythrocyte sedimentation rate increased.
What is Sinemet?
Sinemet has active ingredients of carbidopa; levodopa. It is used in parkinson's disease. Currently, eHealthMe is studying from 28,574 Sinemet users.
What is Erythrocyte sedimentation rate increased?
Erythrocyte sedimentation rate increased is found to be associated with 547 drugs and 1 condition by eHealthMe. Currently, we are studying 2,164 people who have Erythrocyte sedimentation rate increased.
Number of Sinemet and Erythrocyte sedimentation rate increased reports submitted per year:
Gender of people who have Erythrocyte sedimentation rate increased when taking Sinemet *:
- female: 31.58 %
- male: 68.42 %
Age of people who have Erythrocyte sedimentation rate increased when taking Sinemet *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 100 %
Common drugs people take besides Sinemet *:
- Requip: 8 people, 42.11%
- Tasmar: 6 people, 31.58%
- Sporanox: 5 people, 26.32%
- Accolate: 4 people, 21.05%
- Atrovent: 4 people, 21.05%
- Ritalin: 4 people, 21.05%
- Lasix: 4 people, 21.05%
- Proventil: 4 people, 21.05%
- Vitamin E: 3 people, 15.79%
- Eldepryl: 3 people, 15.79%
Common side effects people have besides Erythrocyte sedimentation rate increased *:
- Fever: 14 people, 73.68%
- Cardiac Failure Congestive: 7 people, 36.84%
- Cough: 6 people, 31.58%
- C-Reactive Protein Increased: 6 people, 31.58%
- Idiopathic Pulmonary Fibrosis (chronic lung disease): 6 people, 31.58%
- Pleural Effusion (water on the lungs): 5 people, 26.32%
- Thrombocythaemia (an increased number of platelets in the circulating blood): 5 people, 26.32%
- Crepitations (noises are produced by the rubbing of parts one against the other): 4 people, 21.05%
- White Blood Cell Count Increased: 4 people, 21.05%
- Alveolitis Fibrosing (idiopathic pulmonary fibrosis): 4 people, 21.05%
* Approximation only. Some reports may have incomplete information.
Do you take Sinemet and have Erythrocyte sedimentation rate increased?Check whether Erythrocyte sedimentation rate increased is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Sinemet side effects by duration, gender and age:
- Sinemet side effects (28,574 reports)
Erythrocyte sedimentation rate increased treatments and more:
- Erythrocyte sedimentation rate increased (2,164 reports)
Common drugs associated with Erythrocyte sedimentation rate increased:
All the drugs that are associated with Erythrocyte sedimentation rate increased:
- Erythrocyte sedimentation rate increased (547 drugs)
All the conditions that are associated with Erythrocyte sedimentation rate increased:
- Erythrocyte sedimentation rate increased (1 condition)
How the study uses the data?
The study uses data from the FDA. It is based on carbidopa; levodopa (the active ingredients of Sinemet) and Sinemet (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Phenytek and Gabapentin drug interaction - a second ago
- Alprazolam and Vanos drug interaction - 4 seconds ago
- Augmentin and Mirtazapine drug interaction - 10 seconds ago
- Eplerenone and Cefazolin Sodium drug interaction - 12 seconds ago
- Movicol and Lamictal drug interaction - 34 seconds ago
- Nevanac and Malaise - 35 seconds ago
- Deferiprone and Viagra drug interaction - 41 seconds ago
- Bidil and Sulfamethoxazole drug interaction - 43 seconds ago
- Roxicodone and Somatuline Depot drug interaction - 43 seconds ago
- Zocor and Unevaluable Reaction - 45 seconds ago